Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-13

Clinical Trial Update: Efficacy and Safety of Losartan/Chlorthalidone vs Losartan/Hydrochlorothiazide in Essential Arterial Hypertension [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing losartan/chlorthalidone to losartan/hydrochlorothiazide for essential hypertension has completed, with results on efficacy and safety …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorthalidone (chlorthalidone)
  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • Hyzaar (losartan/hydrochlorothiazide)
  • Losartan (losartan)

Snippet

Sponsor: Laboratorios Silanes S.A. de C.V. | Conditions: Essential Arterial Hypertension | Phase 3 | Status: COMPLETED